Zhende Historical Income Statement

603301 Stock

22.17 0.49 2.16%

Historical analysis of Zhende Medical income statement accounts such as Other Operating Expenses of 58.4 M, Net Income Applicable To Common Shares of 584 M or Income Tax Expense of 119.2 M can show how well Zhende Medical Co performed in making a profits. Evaluating Zhende Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Zhende Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Zhende Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Zhende Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhende Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Zhende Income Statement Analysis

Zhende Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Zhende Medical shareholders. The income statement also shows Zhende investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Zhende Medical Income Statement Chart

At present, Zhende Medical's Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 119.2 M, whereas Interest Expense is forecasted to decline to about 18.6 M.

Income Tax Expense Tax Provision Selling General Administrative

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most accounts from Zhende Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Zhende Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhende Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Gross Profit	1.8B	2.1B	1.4B	1.6B
Total Revenue	5.1B	6.1B	4.1B	4.3B

Gross Profit Total Revenue

Zhende Medical income statement Correlations

	Other Operating Expenses	Income Tax Expense	Minority Interest	Tax Provision	Net Interest Income	Interest Income	Selling General Administrative	Total Revenue	Gross Profit	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Net Income	Ebitda	Reconciled Depreciation
Other Operating Expenses		0.33	-0.22	0.12	0.85	0.88	0.8	0.61	0.51	0.28	0.22	0.35	0.72	0.69	0.72	0.21	0.23	0.46	0.89
Income Tax Expense	0.33		0.79	0.96	0.43	0.31	0.71	0.91	0.96	0.98	0.97	1.0	0.81	0.85	0.83	0.97	0.97	0.99	0.21
Minority Interest	-0.22	0.79		0.82	0.01	-0.09	0.23	0.53	0.64	0.77	0.78	0.78	0.37	0.42	0.38	0.78	0.78	0.71	-0.25
Tax Provision	0.12	0.96	0.82		0.17	0.04	0.6	0.84	0.91	0.99	0.99	0.95	0.72	0.78	0.74	1.0	0.99	0.92	0.02
Net Interest Income	0.85	0.43	0.01	0.17		0.97	0.63	0.53	0.49	0.3	0.25	0.45	0.55	0.56	0.58	0.24	0.25	0.53	0.71
Interest Income	0.88	0.31	-0.09	0.04	0.97		0.62	0.47	0.41	0.19	0.13	0.34	0.52	0.51	0.54	0.12	0.13	0.43	0.78
Selling General Administrative	0.8	0.71	0.23	0.6	0.63	0.62		0.93	0.86	0.72	0.68	0.72	0.97	0.97	0.98	0.67	0.69	0.8	0.77
Total Revenue	0.61	0.91	0.53	0.84	0.53	0.47	0.93		0.99	0.92	0.9	0.92	0.97	0.99	0.98	0.89	0.9	0.95	0.51
Gross Profit	0.51	0.96	0.64	0.91	0.49	0.41	0.86	0.99		0.96	0.95	0.97	0.93	0.96	0.94	0.94	0.95	0.98	0.39
Operating Income	0.28	0.98	0.77	0.99	0.3	0.19	0.72	0.92	0.96		1.0	0.98	0.82	0.86	0.84	1.0	1.0	0.97	0.17
Net Income From Continuing Ops	0.22	0.97	0.78	0.99	0.25	0.13	0.68	0.9	0.95	1.0		0.97	0.79	0.84	0.81	1.0	1.0	0.95	0.12
Ebit	0.35	1.0	0.78	0.95	0.45	0.34	0.72	0.92	0.97	0.98	0.97		0.81	0.86	0.84	0.97	0.97	0.99	0.23
Research Development	0.72	0.81	0.37	0.72	0.55	0.52	0.97	0.97	0.93	0.82	0.79	0.81		0.99	0.99	0.78	0.8	0.87	0.65
Cost Of Revenue	0.69	0.85	0.42	0.78	0.56	0.51	0.97	0.99	0.96	0.86	0.84	0.86	0.99		1.0	0.83	0.85	0.91	0.6
Total Operating Expenses	0.72	0.83	0.38	0.74	0.58	0.54	0.98	0.98	0.94	0.84	0.81	0.84	0.99	1.0		0.8	0.82	0.89	0.64
Income Before Tax	0.21	0.97	0.78	1.0	0.24	0.12	0.67	0.89	0.94	1.0	1.0	0.97	0.78	0.83	0.8		1.0	0.94	0.1
Net Income	0.23	0.97	0.78	0.99	0.25	0.13	0.69	0.9	0.95	1.0	1.0	0.97	0.8	0.85	0.82	1.0		0.95	0.13
Ebitda	0.46	0.99	0.71	0.92	0.53	0.43	0.8	0.95	0.98	0.97	0.95	0.99	0.87	0.91	0.89	0.94	0.95		0.34
Reconciled Depreciation	0.89	0.21	-0.25	0.02	0.71	0.78	0.77	0.51	0.39	0.17	0.12	0.23	0.65	0.6	0.64	0.1	0.13	0.34

Click cells to compare fundamentals

Zhende Medical Account Relationship Matchups

Zhende Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	24.2M	18.3M	25.1M	33.5M	28.9M	18.6M
Other Operating Expenses	16.2M	12.6M	28.2M	48.3M	55.6M	58.4M
Net Income Applicable To Common Shares	130.2M	156.9M	2.5B	595.9M	685.2M	584.0M
Income Tax Expense	21.7M	22.7M	561.2M	99.0M	113.9M	119.2M
Minority Interest	40.9M	284.1M	(125.1M)	(21.9M)	(15.0M)	(14.3M)
Tax Provision	22.7M	561.2M	99.0M	100.0M	5.5M	5.2M
Net Interest Income	(28.9M)	(10.6M)	(11.5M)	(24.0M)	9.0M	9.5M
Interest Income	1.4M	12.2M	15.7M	10.6M	40.0M	42.0M
Selling General Administrative	238.6M	628.0M	513.3M	617.3M	500.5M	394.3M
Total Revenue	1.9B	10.4B	5.1B	6.1B	4.1B	4.3B
Gross Profit	598.9M	4.9B	1.8B	2.1B	1.4B	1.6B
Operating Income	236.2M	3.7B	853.2M	983.6M	444.6M	422.4M
Net Income From Continuing Ops	176.6M	3.0B	720.9M	701.8M	213.4M	202.7M
Ebit	133.8M	165.2M	3.6B	727.2M	836.3M	921.1M
Research Development	51.0M	259.7M	153.1M	227.0M	138.9M	132.2M
Cost Of Revenue	1.3B	5.5B	3.3B	4.0B	2.7B	2.7B
Total Operating Expenses	1.6B	6.6B	4.2B	5.2B	3.7B	3.4B
Income Before Tax	199.2M	3.5B	819.9M	801.7M	218.9M	207.9M
Net Income	156.9M	2.5B	595.9M	679.9M	198.4M	188.5M
Ebitda	288.8M	3.6B	987.0M	1.0B	1.2B	1.2B
Reconciled Depreciation	65.3M	78.6M	142.0M	194.3M	243.0M	132.5M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Zhende Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Zhende Historical Income Statement

About Zhende Income Statement Analysis

Zhende Medical Income Statement Chart

Tax Provision

Zhende Medical income statement Correlations

Zhende Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Zhende Medical income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Zhende Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebit	+ 1.0	Income Tax Expense
Income Before Tax	+ 1.0	Tax Provision
Net Income From Continuing Ops	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Net Income From Continuing Ops

Reconciled Depreciation	- 0.25	Minority Interest
Minority Interest	- 0.22	Other Operating Expenses
Interest Income	- 0.09	Minority Interest